Nuveen Asset Management, LLC Catalent, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 837,435 shares of CTLT stock, worth $47.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

837,435

Previous 875,415 4.34%

Holding current value

$47.3 Million

Previous $39.3 Million 20.19%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$42.56 - $59.82 $1.62 Million - $2.27 Million	-37,980 Reduced 4.34%	837,435 $47.3 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $216,153 - $312,810	6,717 Added 0.77%	875,415 $39.3 Million
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $202,215 - $229,665	-4,575 Reduced 0.52%	868,698 $39.6 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $7.45 Million - $15.7 Million	-233,862 Reduced 21.12%	873,273 $37.9 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $12.9 Million - $21 Million	282,806 Added 34.31%	1,107,135 $72.7 Million

Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $7.22 Million - $14.1 Million	174,496 Added 26.85%	824,329 $37.1 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $5.46 Million - $8.53 Million	75,387 Added 13.12%	649,833 $47 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $1.82 Million - $2.38 Million	20,839 Added 3.76%	574,446 $61.6 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $28.1 Million - $37.1 Million	-298,133 Reduced 35.0%	553,607 $59.7 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $62.5 Million - $72.6 Million	-522,316 Reduced 38.01%	851,740 $109 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $20.1 Million - $26.2 Million	-183,758 Reduced 11.8%	1,374,056 $183 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $603,745 - $696,106	6,017 Added 0.39%	1,557,814 $168 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $12.2 Million - $15.1 Million	120,413 Added 8.41%	1,551,797 $163 Million
Q4 2020 May 17, 2021	SELL	$85.88 - $105.36 $4.69 Million - $5.75 Million	-54,585 Reduced 3.67%	1,431,384 $149 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $1.04 Million - $1.28 Million	12,130 Added 0.82%	1,485,969 $155 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $43.1 Million - $54.8 Million	591,979 Added 67.13%	1,473,839 $126 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $23.5 Million - $38.7 Million	489,646 Added 124.84%	881,860 $64.6 Million
Q1 2020 May 14, 2020	SELL	$36.95 - $62.95 $4.21 Million - $7.17 Million	-113,829 Reduced 22.49%	392,214 $20.4 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $494,177 - $594,776	-10,501 Reduced 2.03%	506,043 $28.5 Million
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $4.25 Million - $5.2 Million	89,618 Added 20.99%	516,544 $24.6 Million
Q2 2019 Aug 15, 2019	BUY	$39.26 - $54.21 $16.8 Million - $23.1 Million	426,926 New	426,926 $23.1 Million

Others Institutions Holding CTLT

# of Institutions

484

Shares Held

172M

Call Options Held

865K

Put Options Held

687K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.2B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Catalent, Inc. Transaction History